Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RIOT vs MRNA✓SelectedUSD · MRNARIOT vs MRNA performance historyLatest closeAs of-8.46%11/20
Stock and ETF performance explorer

RIOT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+43.4%
MRNA return
+153.9%
Excess return
-110.5%
Maximum drawdown
-66.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-8.5%-2.2%-6.3%-8.3%
7D-7.4%-12.7%+5.3%-6.2%
30D+15.8%-20.7%+36.4%+18.4%
3M-22.6%+46.3%-68.9%-25.4%
6M-31.4%+305.2%-336.7%-48.7%
YTD+28.1%+561.2%-533.1%-17.1%
1Y+27.0%+772.1%-745.1%-23.6%
3Y+43.4%+147.0%-103.6%+22.4%
All+43.4%+153.9%-110.5%+22.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling